Differences between Grades G1 and G2 Hypovascular Pancreatic Neuroendocrine Tumors and Pancreatic Neuroendocrine Carcinoma
- 1 October 2017
- journal article
- editorial
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 285 (1), 331-332
- https://doi.org/10.1148/radiol.2017171126
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- Nonhypervascular Pancreatic Neuroendocrine Tumors: Differential Diagnosis from Pancreatic Ductal Adenocarcinomas at MR Imaging—Retrospective Cross-sectional StudyRadiology, 2017
- Differentiation of pancreatic neuroendocrine carcinoma from pancreatic ductal adenocarcinoma using magnetic resonance imaging: The value of contrast-enhanced and diffusion weighted imagingOncotarget, 2017
- Prediction of pancreatic neuroendocrine tumour grade with MR imaging features: added value of diffusion-weighted imagingEuropean Radiology, 2016
- The value of gadoxetic acid-enhanced and diffusion-weighted MRI for prediction of grading of pancreatic neuroendocrine tumorsActa Radiologica, 2014
- Intravoxel Incoherent Motion Diffusion-weighted MR Imaging for Characterization of Focal Pancreatic LesionsRadiology, 2014
- Evaluation of ADC measurements among solid pancreatic masses by respiratory-triggered diffusion-weighted MR imaging with inversion-recovery fat-suppression technique at 3.0TMagnetic Resonance Imaging, 2013
- Neuroendocrine Pancreatic Tumors: Guidelines for Management and UpdateCurrent Treatment Options in Oncology, 2011
- Diffusion‐weighted MR imaging in pancreatic endocrine tumors correlated with histopathologic characteristicsJournal of Magnetic Resonance Imaging, 2011
- Everolimus for Advanced Pancreatic Neuroendocrine TumorsThe New England Journal of Medicine, 2011
- Sunitinib Malate for the Treatment of Pancreatic Neuroendocrine TumorsThe New England Journal of Medicine, 2011